Search Results - "Radican, L"

Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy by Fu, A. Z., Qiu, Y., Davies, M. J., Radican, L., Engel, S. S.

“…Aim: To evaluate the time to and factors associated with treatment intensification in patients with type 2 diabetes who failed metformin monotherapy. Methods:…”
Get full text

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial by Al Sifri, S, Basiounny, A, Echtay, A, Al Omari, M, Harman-Boehm, I, Kaddaha, G, Al Tayeb, K, Mahfouz, A S, Al Elq, A, Radican, L, Ozesen, C, Katzeff, H L, Musser, B J, Suryawanshi, S, Girman, C J, Davies, M J, Engel, S S

“…To compare the incidence of symptomatic hypoglycaemia in fasting Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during…”
Get more information

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy by Inzucchi, S. E., Tunceli, K., Qiu, Y., Rajpathak, S., Brodovicz, K. G., Engel, S. S., Mavros, P., Radican, L., Brudi, P., Li, Z., Fan, C. P. S., Hanna, B., Tang, J., Blonde, L.

“…Aim To assess time to insulin initiation among patients with type 2 diabetes mellitus (T2DM) treated with sitagliptin versus sulphonylurea as add‐on to…”
Get full text

Cost-Effectiveness of Sitagliptin Versus Sulfonylurea As An Add-On Therapy To Metformin In Patients With Type 2 Diabetes In A Belgium Setting by Chen, J, Radican, L, Shankar, R, Hiver, M, Qiu, Y

Get full text

PO194 MEDICATION ADHERENCE, PERSISTENCE, AND DISCONTINUATION PATTERNS AMONG PATIENTS PRESCRIBED DIPEPTIDYL PEPTIDASE-4 INHIBITOR THERAPY IN JAPAN by Tunceli, K, Kurtyka, K, Nishikino, R, Ito, C, Radican, L, Brodovicz, K, Chen, Y

Get full text

Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes by Zhang, Q., Rajagopalan, S., Marrett, E., Davies, M. J., Radican, L., Engel, S. S.

“…Aim: To compare the time from initial diagnosis to initiation with oral antihyperglycaemic treatment in younger versus older patients with type 2 diabetes, and…”
Get full text

Costs of Hospitalization of Type 2 Diabetic Patients Associated with Severe Hypoglycemia by Laires, P, Conceição, J, Araújo, F, Dores, J, Silva, C, Radican, L, Nogueira, A.M

Get full text

Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room): Clinical Outcomes in Admitted Patients by Conceição, J, Dores, J, Araújo, F, Laires, P, Carr, R, Brodovicz, K, Radican, L, Nogueira, A.M

Get full text

Hipos-Er (Hypoglycemia in Portugal Observational Study – Emergency Room): Costs And Health Care Resource Consumption Data by Laires, P, Conceição, J, Araújo, F, Dores, J, Silva, C, Radican, L, Nogueira, A.M

Get full text

Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room): Outcomes with Different Anti-Hyperglycemic Agents by Conceição, J, Laires, P, Dores, J, Araújo, F, Carr, R, Brodovicz, K, Radican, L, Vicente, V, Nogueira, A.M

Get full text

Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room): Clinical Outcomes in the Emergency Room by Conceição, J, Dores, J, Araújo, F, Laires, P, Carr, R, Brodovicz, K, Radican, L, Nogueira, A.M

Get full text

Cost Analysis of Severe Hypoglycemia in Treated Type 2 Diabetic Patients According to Anti-Hyperglycemic Agent Therapy by Laires, P, Conceição, J, Dores, J, Araújo, F, Silva, C, Radican, L, Nogueira, A.M

Get full text

PO368 DISCONTINUATION AND ADHERENCE FOR SITAGLIPTIN VERSUS SULFONYLUREA AS ADD-ON TO METFORMIN by Tunceli, K, Zhao, C.G, Brodovicz, K, Mavros, P, Engel, S, Radican, L, Rajpathak, S, Qiu, Y, Brudi, P, Yong, C, Bloomgarden, Z, Fonseca, V

Get full text

Factors Associated with Hospitalization of Type 2 Diabetic Patients with Hypoglycemic Episodes Assisted at Emergency Departments by Conceição, J, Laires, P, Araújo, F, Dores, J, Vicente, V, Silva, C, Carr, R, Brodovicz, K, Radican, L, Nogueira, A.M

Get full text

Impact of concurrent macrovascular co-morbidities on healthcare utilization in patients with type 2 diabetes in Europe: a matched study by Fu, A. Z., Qiu, Y., Radican, L., Yin, D. D., Mavros, P.

“…Aim: To examine and to quantify the impact of concurrent macrovascular co‐morbidities (MVC) on healthcare resource utilization among patients with type 2…”
Get full text

Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium by Richy, F., Gourlay, M., Ross, P.D., Sen, S.S., Radican, L., De Ceulaer, F., Ben Sedrine, W., Ethgen, O., Bruyere, O., Reginster, J.-Y.

“…Background: Risk indices have been developed to identify women at risk of low bone mineral density (BMD) who should undergo BMD testing. Aim: To compare the…”
Get full text

PDB8 EFFECTIVENESS AND ADHERENCE WITH FIXED-DOSE COMBINATION (FDC) VERSUS COADMINISTERED DUAL THERAPY (CDT) ANTIHYPERGLYCEMIC REGIMENS: A META-ANALYSIS by Han, S, Davies, M.J, Lento, K, Radican, L, Zhang, Q

Get full text

PCV127 Time to Initiation of Oral Antihyperglycaemic and Statin Therapy in Patients with Newly Diagnosed Type 2 Diabetes Mellitus by Tunceli, K, Sun, P, Seck, T, Ambegaonkar, B, Lento, K, Davies, M.J, Zhang, Q, Radican, L

Get full text

PDB78 Reasons of UK General Practitioners for Prescribing 15- or 30-Mg of Pioglitazone in Combination with Other Oral Antihyperglycaemic Agents by Tunceli, K, Lento, K, Zhang, Q, Jameson, K, Meiler, S, Davies, M.J, Steinberg, H, Brodovicz, K, Radican, L, Sinclair, A

Get full text

P106 HIPOS-ER (Hypoglycemia in Portugal observational study – Emergency room): données concernant les coûts et l’utilisation des ressources de santé by Moisan, C, Laires, P, Conceição, J, Dores, J, Silva, C, Radican, L, Nogueira, A.M, Araùjo, F

“…Objectif HIPOS-ER est une étude nationale observationnelle, transversale et multicentrique décrivant la population de patients diabétiques de type 2 admis aux…”
Get full text